“五参芪苓丸”为国家三类中药新药,200例Ⅱ期临床试验结果表明:本品对证属气阴两虚,血瘀肝郁的原发性肝癌具有一定的疗效,能延缓病情,使部分病例瘤体缩小,延长患者生存时间,提高生活质量,且元明显的毒副作用。广东阳江制药厂由长春振环抗癌药物研究所引进该产品,在国内独家生产 “Wen Shen Pi Pill” is a national three new type of traditional Chinese medicine, and 200 cases of Phase II clinical trials have shown that this product has a certain effect on the primary liver cancer with Qi and Yin deficiency, blood stasis and liver turbidity, and can delay the illness. In some cases, the tumor shrinks, prolongs the patient’s survival time, improves the quality of life, and has obvious toxic side effects. Guangdong Yangjiang Pharmaceutical Factory introduced this product from the Changchun Zhenhuan Anti-cancer Drug Research Institute and is exclusively produced in China.